Publication:
Reply to Kuniholm et al.

dc.contributor.authorDominguez-Molina, Beatriz
dc.contributor.authorTarancon-Diez, Laura
dc.contributor.authorLeal, Manuel
dc.contributor.authorRuiz-Mateos, Ezequiel
dc.date.accessioned2023-01-25T09:46:33Z
dc.date.available2023-01-25T09:46:33Z
dc.date.issued2017
dc.identifier.doi10.1093/cid/cix482
dc.identifier.essn1537-6591
dc.identifier.pmid28541465
dc.identifier.unpaywallURLhttps://academic.oup.com/cid/article-pdf/65/7/1244/19918678/cix482.pdf
dc.identifier.urihttp://hdl.handle.net/10668/11235
dc.issue.number7
dc.journal.titleClinical infectious diseases : an official publication of the Infectious Diseases Society of America
dc.journal.titleabbreviationClin Infect Dis
dc.language.isoen
dc.organizationIBIS
dc.page.number1244-1245
dc.pubmedtypeLetter
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.pubmedtypeComment
dc.rights.accessRightsopen access
dc.subject.meshDisease Progression
dc.subject.meshHIV Seropositivity
dc.subject.meshHIV-1
dc.subject.meshHLA-B Antigens
dc.subject.meshHumans
dc.titleReply to Kuniholm et al.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number65
dspace.entity.typePublication

Files